AI, Big Data will be the most impactful emerging technologies for pharma in 2023: GlobalData Read more
Inflation, drug pricing and reimbursement constraints will have the biggest negative impact on biopharma industry in 2023: GlobalData Read more
Top 20 global biopharma companies report 9.1 per cent QoQ decline in market capitalisation during Q3 2022: GlobalData Read more
Promising pipeline drugs to transform Fragile X Syndrome treatment market by 2030: GlobalData Read more